Introduction
Acute severe mitral regurgitation (MR) is a medical, and often surgical emergency, associated with acute pulmonary oedema and/or cardiogenic shock. While prompt surgical intervention is generally the definitive therapy, there are situations where the availability, or the risk/ benefit ratio, of cardiac surgery necessitates interim stabilization with medical management and mechanical circulatory support (MCS).
Learning points
• Acute severe mitral regurgitation associated with cardiogenic shock is associated with high peri-procedural mortality.
• TandemHeart, with or without extracorporeal membrane oxygenation, can facilitate haemodynamic stabilization and bridge to surgery with successful surgical and patient outcomes. Studies have shown the perioperative mortality rate of patients undergoing mitral valve surgery for acute severe MR ranges from 14.8% to 27%.
1 Furthermore, surgical outcomes in patients undergoing surgery with shock physiology are significantly worse compared to patients without cardiogenic shock. [2] [3] [4] Traditionally, placement of an intra-aortic balloon pump (IABP) has been utilized due to its ability to augment cardiac output and decrease afterload, thereby supporting mean arterial pressure and potentially decreasing MR. 5 Alternatively, newer MCS devices such as the Impella V R (Abiomed, Danvers, MA, USA) and TandemHeart V R (TH) (LivaNova, London, UK) left ventricular (LV) assist devices could be used. The Impella V R axial flow pump can be rapidly deployed, provide haemodynamic support, and effect LV decompression. However, neither the IABP nor the Impella V R can ameliorate severe refractory hypoxaemia from acute pulmonary oedema. The TH is unique in its ability to offer solutions to both hypotension and hypoxaemia due to poor forward stroke volume. Inserted percutaneously, a left atrial (LA) drainage cannula is placed by transseptal puncture across the interatrial septum ( Figure 1) , with an arterial return cannula placed in the femoral artery. When hypoxaemia is an additional challenge, an oxygenator can be spliced into the circuit, akin to peripheral veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO). We report on two patients with acute severe MR presenting with cardiogenic shock and profound hypoxaemia bridged to surgery and recovery with use of a TH-ECMO approach.
Timeline Case presentation Case 1
A 47-year-old man without significant medical history initially presented to an outside facility with severe, progressive shortness of breath over 3 weeks with sudden onset haemoptysis requiring intubation. An emergent echocardiogram revealed severe MR with flail posterior mitral leaflet and ruptured chordae tendinae, and LV ejection fraction of 65-70% (Figures 2 and 3) (Supplementary material online, Videos S1-S5). Given refractory hypoxaemia, the patient was transferred to our facility for consideration of veno-venous (V-V) ECMO and/or IABP support as a bridge to surgery.
Upon arrival to our cath lab, heart rate was 115 b.p.m., blood pressure 94/60 mmHg (on norepinephrine 4 lg/kg/min), respiratory rate 26 breaths per min, SpO 2 78% on mechanical ventilation with FiO 2 100%, and positive end expiratory pressure (PEEP) 18 mmHg. Physical exam revealed three of six harsh systolic murmur at LV apex radiating to second right intercostal space with bilateral wet rales to apical lung fields.
ECG showed sinus tachycardia without significant ST-T changes. Labs showed white blood count (WBC) 19.9 k/lL [upper limit of normal (ULN) 12 k/lL], serum creatinine 1.83 mg/dL up from 1.09 mg/dL (ULN 1.3 mg/dL), lactic acid 2.3 mmol/L (normal <2 mmol/L), troponin-I <0.03 pg/dL (normal < 0.03 ng/mL), and arterial blood gas (ABG) pre-TH pH 7.14/PaCO 2 58 mmHg/PaO 2 43 mmHg/HCO 3 20 mmol/L on FiO 2 100%. Chest X-ray showed bilateral diffuse pulmonary oedema ( Figure 4 ). Given cardiogenic shock physiology with severe refractory hypoxaemia, a decision was made to unload the left atrium with a TH device. An oxygenator was spliced onto the arterial return cannula akin to V-A ECMO with improvement in the arterial PaO 2 to 599 mmHg. Subsequent coronary angiography revealed normal coronary arteries. Hypothermia was instituted for neuroprotection given severe persistent hypoxaemia. The patient remained on the TH-ECMO circuit for 48 h with a decrease in pulmonary vascular congestion ( Figure 5 ) and improved lung compliance. Patient subsequently underwent mitral valve replacement with a 31-mm bioprosthesis, removal of the TH-ECMO circuit, and repair of the interatrial septum. The patient was successfully discharged home on Day 12 of hospitalization without any neurological deficits.
Case 2
A 49-year-old man with hypertension, hypertriglyceridaemia, and moderate alcohol use presented with acute onset of chest pain and dyspnoea that awoke him from sleep. Vitals on presentation were heart rate 134 b.p.m., blood pressure 117/79 mmHg, respiratory rate 28 breaths per min, and SpO 2 91% on 6 L/min O 2 nasal cannula.
Physical exam was significant for a blowing pan systolic murmur at LV apex and bilateral rales. Initial troponin-I was 3.07 ng/mL (normal < 0.03 ng/mL), which trended up to 73.5 ng/mL on arrival to cath lab, and peaked at 119.6 ng/mL. Lactic acid level was 5.5 mmol/L (normal < 2 mmol/L). Serum creatinine was 1.36 mg/dL up from 0.92 mg/dL (ULN 1.3 mg/ dL). Chest X-ray showed bilateral pulmonary vascular congestion. EKG showed sinus tachycardia with ST depressions in V2-V5 consistent with a posterior wall infarction. An emergent echocardiogram revealed severe MR with complete rupture of the posterior papillary muscle and flail posterior mitral leaflet (Figures 6 and 7) (Supplementary material online, Videos S6 and S7). Left ventricular ejection fraction was 50-55% with mild hypokinesis of the lateral wall. Upon arrival to the catheterization lab, patient had further deterioration with peripheral saturation of 80% on 100% nonrebreather mask necessitating endotracheal intubation and mechanical ventilation. Post-intubation, pink, frothy sputum was noted in the Post-operative course was complicated by seizures as a manifestation of a mild left Sylvian fissure subarachnoid haemorrhage and small subacute ischaemic infarcts, possibly related to the emergent TH insertion procedure. Despite this, patient made a full neurologic recovery (cerebral performance category 1) with no residual deficits and was discharged home on hospital Day 15.
Discussion
Acute severe MR was caused by myxomatous mitral valve degeneration complicated by chordal rupture in Case 1 and acute myocardial infarction complicated by complete papillary muscle rupture in Case 2. Emergent surgical intervention remains the treatment of choice for management of symptomatic acute MR but is associated with high perioperative mortality when complicated by cardiogenic shock. 1, 3 Both of our patients were triaged as intermediate to high surgical risk post-TH-ECMO stabilization and lung decompression, as evidenced by the Society of Thoracic Surgery (STS) scores of 4.047% and 17.6%, respectively. Specifically, in patients with post-infarction papillary muscle rupture, a high risk, as assessed by a EuroSCORE II >25%, has been shown to be an independent predictor of in-hospital mortality. Acute severe MR leads to a variety of haemodynamic changes primarily related to the abrupt onset without time for LA adaptation. A significant increase in the LA and pulmonary venous pressures occur from acute volume overload of a non-compliant LA resulting in severe pulmonary oedema induced hypoxaemia. Additionally, there is a drop in cardiac output due to a decrease in effective forward stroke volume across the aortic valve contributing to cardiogenic shock physiology. A compensatory systemic vasoconstrictor response increases the systemic afterload and further aggravates the MR. 6 In cardiogenic shock due to acute myocardial infarction or decompensated heart failure, the TH has been shown to produce greater haemodynamic benefit than the IABP, generating a greater increase in cardiac index and mean arterial blood pressure with a significant decrease in pulmonary capillary wedge pressure, but without a mortality benefit vis-à-vis an IABP. 7 The TH is a percutaneous LV assist device driven by a centrifugal pump, which works by extracting oxygenated blood from the left atrium via an outflow LA cannula placed by transseptal puncture across the interatrial septum. The blood is then circulated extracorporeally through the pump and returned via an inflow cannula into the femoral artery. By directly extracting blood from the LA and thus decompressing the LA, the TH helps to remove the increased LA volume created by acute MR. This, in turn, decreases LA pressure and subsequently decreases pulmonary venous pressure and pulmonary congestion. Additionally, because the TH returns blood directly to the systemic arterial vasculature, it augments native cardiac output and maintains organ perfusion. The TH can generate 3.5-4.5 L/min of cardiac output. Furthermore, the TH system allows for the addition of an oxygenator to be spliced into the arterial return circuit when hypoxaemia is an additional challenge as a result of poor oxygenation of blood in the pulmonary vasculature due to severe pulmonary oedema.
Use of a TH in an elective manner for acute MR with severe pulmonary hypertension to facilitate RV decompression to optimize surgical outcomes has been described. 8 Our cases are unique in that both patients were in profound cardiogenic shock with severe hypoxaemia that mandated an emergent TH insertion. Use of the TH device with an oxygenator (TH-ECMO) provided prompt stabilization of the haemodynamics and refractory hypoxaemia allowing for early surgery in both patients with good outcomes. Bleeding, vascular injury, cardiac/aortic perforation, pericardial tamponade, stroke resultant to air embolism and/or thrombus formation, membrane activation from ECMO, and leg ischaemia are risks associated with TH-ECMO placement. Use of vascular ultrasound for peripheral access, intracardiac echo guidance, and/or transoesophageal echo to guide transseptal puncture, and meticulous attention to prevent air embolism help minimize complications and increase procedural safety.
Conclusion
Acute MR complicated by cardiogenic shock is a medical emergency, associated with a high mortality even after valvular and coronary artery bypass surgery. Our report demonstrates that using a TH-ECMO bridge to open-heart surgery can facilitate better surgical and patient outcomes. Future studies focusing on stabilizing such patients with an earlier application of TH-ECMO or other MCS device might help define the optimal timing for intervention in these patients. 
Supplementary material
Supplementary material is available at European Heart Journal -Case Reports online.
Slide sets: A fully edited slide set detailing this case and suitable for local presentation is available online as Supplementary data.
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